Keita Wada

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

Fuyuhiko Motoi, Tomoo Kosuge, Hideki Ueno et al. · Japanese Journal of Clinical Oncology · 2018 · 534 citations · Full text

Medicine, Oncology, Surgery +15

Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines

Yasutoshi Kimura, Tadahiro Takada, Yoshifumi Kawarada et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2007 · 490 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +11

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Chigusa Morizane, Takuji Okusaka, Junki Mizusawa et al. · Annals of Oncology · 2019 · 334 citations

Medicine, Oncology, Chemotherapy +7

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines

Keita Wada, Tadahiro Takada, Yoshifumi Kawarada et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2007 · 255 citations · Full text

Medicine, Internal Medicine, Hepatology +7

Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery

Manabu Kawai, Satoshi Kondo, Hiroki Yamaue et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2011 · 222 citations · Full text

Medicine, Perioperative Medicine, Surgery +16